TA162: Lung cancer (non-small-cell) - erlotinib
This is a discussion on TA162: Lung cancer (non-small-cell) - erlotinib within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Lung cancer (non-small-cell) - erlotinib . It links to the published guidance ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
11-26-2008, 12:03 AM
|
|||
|
|||
TA162: Lung cancer (non-small-cell) - erlotinib
The summary for the published technology appraisal on Lung cancer (non-small-cell) - erlotinib . It links to the published guidance and key documents.
More... Last edited by chantell.reagan : 12-18-2008 at 10:26 AM. 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Gefitinib as Effective as Docetaxel in Non-Small-Cell Lung Cancer | industry_news | Other Clinical Pharmacy News | 0 | 11-25-2008 06:13 PM |
| First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line | industry_news | Other Clinical Pharmacy News | 0 | 10-08-2008 09:21 AM |
| Tumor Size Important Indicator for Survival in Lung Cancer | industry_news | Other Clinical Pharmacy News | 0 | 09-04-2008 05:15 PM |
| Investigational Drug Combination Plus Chemotherapy Promising in Breast Cancer Cell Lines | industry_news | Other Clinical Pharmacy News | 0 | 07-03-2008 10:13 AM |
| Avastin, Erbitux battle for lung cancer market | industry_news | Biotechnology News | 0 | 04-22-2008 10:52 AM |
© 2008 DrugManagementForum™ powered by |
 |